According to GuruFocus Insider Data, the recent CFO sells were: WEC Energy Group Inc (WEC, Financial) and Regeneron Pharmaceuticals Inc. (REGN, Financial).
WEC Energy Group Inc.: Executive VP and CFO Scott J Lauber sold 1,500 shares
On Aug. 23, Executive VP and CFO Scott J Lauber sold 1,500 shares at an average price of $65. The price of the stock has increased by 0.15%. WEC Energy Group Inc. has a market cap of $20.54 billion and its shares were traded around $65.10. The company has a P/E ratio of 21.42 and P/S ratio of 2.71. The trailing 12-month dividend yield of WEC Energy Group Inc. stocks is 3.17%, while the forward dividend yield is 3.20%. Over the past 10 years, WEC Energy Group Inc. had an annual average earnings growth of 7.10% . GuruFocus rated Wec Energy Group Inc. the business predictability rank of 3.5-star.
WEC Energy Group announced its second-quarter results with revenue of $1.63 billion and gross profit of $609.9 million, while the net income was $199.4 million. The 2016 total revenue was $7.47 billion, a 26% increase from 2015. The 2016 gross profit was $2.64 billion, a 34% increase from the year prior. The 2016 net income was $940.2 million.
On Aug. 24, Director Gale E Klappa sold 12,632 shares at an average price of $65.04. The price of the stock has increased by 0.09%. On Aug. 18, Director Barbara L Bowles sold 1,500 shares at an average price of $64.68. The price of the stock has increased by 0.65%.
Regeneron Pharmaceuticals Inc.: SVP Finance and CFO Robert E Landry sold 468 shares
On Aug. 23, SVP Finance and CFO Robert E Landry sold 468 shares at an average price of $476.45. The price of the stock has increased by 0.28%. Regeneron Pharmaceuticals Inc. has a market cap of $51.2 billion and its shares were traded around $477.80. The company has a P/E ratio of 47.94 and P/S ratio of 10.58.
Regeneron Pharmaceuticals announced its second-quarter results with revenue of $1.47 billion and gross profit of $1.37 billion, while the net income was $387.74 million. The 2016 total revenue was $4.86 billion, a 18% increase from 2015. The 2016 gross profit was $4.56 billion, a 23% increase from the year prior. The 2016 net income was $895.52 million.
On Aug. 24, 10% Owner Sanofi bought 166,415 shares at an average price of $480.93. The price of the stock has decreased by 0.65%. On Aug. 22, Chairman of the Board P Roy Vagelos sold 56,213 shares at an average price of $474.48. The price of the stock has increased by 0.7%.
Disclosure: none
